Next, we demonstrated that the level of PAI-1 is significantly elevated in the serum samples of IBD patients versus the control subjects [24.62 ng/mL vs 30.48 ng/mL, p = 0.0409] [Figure 1A]. This evidence concerns the gene SERPINE1 and irritable bowel syndrome.